Literature DB >> 26633755

Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions.

Kelly N H Nudelman1, Brenna C McDonald2, Andrew J Saykin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26633755      PMCID： PMC4822502          DOI： 10.1001/jamaoncol.2015.4551

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  15 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.

Authors:  Brenna C McDonald; Susan K Conroy; Dori J Smith; John D West; Andrew J Saykin
Journal:  Brain Behav Immun       Date:  2012-05-18       Impact factor: 7.217

3.  Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study.

Authors:  Carole Scherling; Barbara Collins; Joyce Mackenzie; Catherine Bielajew; Andra Smith
Journal:  J Clin Exp Neuropsychol       Date:  2012-03-02       Impact factor: 2.475

4.  Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.

Authors:  Sunita K Patel; Andrew L Wong; F Lennie Wong; Elizabeth Crabb Breen; Arti Hurria; Mackenzie Smith; Christine Kinjo; I Benjamin Paz; Laura Kruper; George Somlo; Joanne E Mortimer; Melanie R Palomares; Michael R Irwin; Smita Bhatia
Journal:  J Natl Cancer Inst       Date:  2015-06-22       Impact factor: 13.506

5.  Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls.

Authors:  Shelli R Kesler; Jeffrey S Wefel; S M Hadi Hosseini; Maria Cheung; Christa L Watson; Fumiko Hoeft
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

6.  Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study.

Authors:  Julie A Dumas; Jenna Makarewicz; Geoffrey J Schaubhut; Robert Devins; Kimberly Albert; Kim Dittus; Paul A Newhouse
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

7.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  Breast Cancer Res Treat       Date:  2010-08-06       Impact factor: 4.872

8.  Prechemotherapy alterations in brain function in women with breast cancer.

Authors:  Bernadine Cimprich; Patricia Reuter-Lorenz; James Nelson; Patricia M Clark; Barbara Therrien; Daniel Normolle; Marc G Berman; Daniel F Hayes; Douglas C Noll; Scott Peltier; Robert C Welsh
Journal:  J Clin Exp Neuropsychol       Date:  2009-07-29       Impact factor: 2.475

9.  Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.

Authors:  Shelli R Kesler; Douglas W Blayney
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

10.  Altered small-world properties of gray matter networks in breast cancer.

Authors:  S M Hadi Hosseini; Della Koovakkattu; Shelli R Kesler
Journal:  BMC Neurol       Date:  2012-05-28       Impact factor: 2.474
View more
  1 in total

1.  Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy.

Authors:  Andrew P Speidell; Tamar Demby; Yichien Lee; Olga Rodriguez; Christopher Albanese; Jeanne Mandelblatt; G William Rebeck
Journal:  Neurotox Res       Date:  2018-10-04       Impact factor: 3.911
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.